Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DYNC2LI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SREK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOLR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCAP29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC23A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM254 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEPDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on